{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "NCIT": "^C\\d+$",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/4aa36980578c7d2cff07371abf768f15db89cd11/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
    },
    "path": "hypoxia/zhang2011.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "key": "e46464f8a12cefeb9bf4541b31ff8cfe",
      "relation": "partOf",
      "source": 111,
      "target": 54
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "90f73b866e15e762887fcff037d14bee",
      "line": 320,
      "relation": "positiveCorrelation",
      "source": 111,
      "target": 25
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 activation promotes cellular response to low oxygen, reduced glucose supply, and oxidative stress.",
      "key": "70e6201794b4856fdfe876363c11eab1",
      "line": 362,
      "relation": "increases",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 31
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 activation promotes cellular response to low oxygen, reduced glucose supply, and oxidative stress.",
      "key": "1980fd8b10240fb4a9e55d09afcd9782",
      "line": 363,
      "relation": "increases",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 30
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "3edd0ce501f67a3b1e02ef2c4761dfa2",
      "line": 400,
      "relation": "increases",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 44
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "d4a45350c1134b325cc143327c135a7d",
      "line": 401,
      "relation": "increases",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 41
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "56b4baadd833ba7ae0009890a1b7bdbe",
      "line": 402,
      "relation": "decreases",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 6
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 can induce the erythropoiesis and angiogenesis to increase oxygen delivery and supply [3]. Thus, an increase of HIF-1 activity might reduce the risk of AD by suppressing the Aβ generation and AD occurrence induced by hypoxia.",
      "key": "994877827d87ed9a5d47ebbbc30ce66c",
      "line": 403,
      "relation": "decreases",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 116
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10090": true,
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is reported that MPTP treatment inhibits HIF-1α accumulation in dopaminergic cell lines PC12 and in mice [80], suggesting that HIF-1 activity is impaired in PD.",
      "key": "4453f02321f0bacee44aa3ab03e2c729",
      "line": 438,
      "relation": "negativeCorrelation",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 117
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, through increasing synthesis and secretion of DA, HIF-1 may prevent the PD pathological process.",
      "key": "4a4ad3438e53dee2d766755ab35bcaa9",
      "line": 482,
      "relation": "decreases",
      "source": 111,
      "target": 117
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, through increasing synthesis and secretion of DA, HIF-1 may prevent the PD pathological process.",
      "key": "e9da401890db80e1ced13fd8eec19f20",
      "line": 480,
      "relation": "increases",
      "source": 111,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, through increasing synthesis and secretion of DA, HIF-1 may prevent the PD pathological process.",
      "key": "764899f08ccb40f5003c4ae235338eba",
      "line": 481,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 111,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 regulates glycolysis and hexose monophosphate shunt, which increases the production of adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide phosphate (NADPH) for cell survival.",
      "key": "f8c12b09dad911ec220997d41b0d596d",
      "line": 554,
      "relation": "increases",
      "source": 111,
      "target": 11
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 regulates glycolysis and hexose monophosphate shunt, which increases the production of adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide phosphate (NADPH) for cell survival.",
      "key": "5654e39f3d5a9d4b6875bc85a7ced857",
      "line": 555,
      "relation": "increases",
      "source": 111,
      "target": 12
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "HIF-1 regulates glycolysis and hexose monophosphate shunt, which increases the production of adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide phosphate (NADPH) for cell survival.",
      "key": "ce9a0c7f1c839dc0950c36c8771fb073",
      "line": 556,
      "relation": "increases",
      "source": 111,
      "target": 43
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, increasing HIF-1 activity may prevent neurons from mutant huntingtin protein damage.",
      "key": "81905ccaff80a3356bb69a2366618c7b",
      "line": 561,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 111,
      "subject": {
        "modifier": "Activity"
      },
      "target": 95
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Therefore, HIF-1 induction may provide cytoprotection by increasing energy supply and contributing to cellular redox homeostasis.",
      "key": "d6ff950e3d424f57bc9d7232002aed79",
      "line": 583,
      "relation": "increases",
      "source": 111,
      "target": 29
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "849b0efe19286de012db4289941b4c4c",
      "line": 647,
      "relation": "increases",
      "source": 111,
      "target": 76
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "70de7ed3a9a31a557f4dfe2da7cdbcd6",
      "line": 648,
      "relation": "increases",
      "source": 111,
      "target": 106
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "9928955ab8ab8c2705d5d3a388cefe45",
      "line": 649,
      "relation": "increases",
      "source": 111,
      "target": 71
    },
    {
      "key": "5ac62b5a06a2e29b29a97d25e0ae3951",
      "relation": "partOf",
      "source": 80,
      "target": 111
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The activity of HIF-1 is mainly controlled through regulating the protein level of HIF-1α [3].",
      "key": "c19a94441e83624a991978cb25cc52d8",
      "line": 104,
      "object": {
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 80,
      "target": 111
    },
    {
      "key": "293d7af70873d72e5ee6a975a372f10e",
      "relation": "partOf",
      "source": 80,
      "target": 49
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Under hypoxia, HIF-1α is stabilized and translocated to the nucleus where it dimerizes with HIF-1β [3].",
      "key": "2d4f8d6fe5eb569d7b0c2fd303ce09c9",
      "line": 92,
      "object": {
        "location": {
          "name": "nucleus",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 80,
      "subject": {
        "location": {
          "name": "nucleus",
          "namespace": "GO"
        }
      },
      "target": 49
    },
    {
      "key": "439625471e10b826b802021406af9370",
      "relation": "hasVariant",
      "source": 80,
      "target": 83
    },
    {
      "key": "91fb70a2a85bf467f7d11a1a9ab66fe7",
      "relation": "hasVariant",
      "source": 80,
      "target": 84
    },
    {
      "key": "f3a85755ac4a654e41b2ee5ab98fefca",
      "relation": "partOf",
      "source": 80,
      "target": 52
    },
    {
      "key": "b84a6178a02b5bf2a4a7882304df87d8",
      "relation": "hasVariant",
      "source": 80,
      "target": 91
    },
    {
      "key": "67c79d9eb71e2d619d46cf4fbd60b14b",
      "relation": "hasVariant",
      "source": 80,
      "target": 82
    },
    {
      "key": "dbb3daf9fa8226bd47f5c89fc25d777d",
      "relation": "partOf",
      "source": 80,
      "target": 50
    },
    {
      "key": "e71fee122f99e5c3b16784856b76ed2d",
      "relation": "partOf",
      "source": 80,
      "target": 51
    },
    {
      "key": "429b388e0e12a23212327287d64d673c",
      "relation": "hasVariant",
      "source": 80,
      "target": 81
    },
    {
      "key": "2ed2a2af884849ce7f32b68d09e36747",
      "relation": "hasVariant",
      "source": 80,
      "target": 92
    },
    {
      "key": "2306ed29240f3cac2993ac60fed95882",
      "relation": "hasVariant",
      "source": 80,
      "target": 89
    },
    {
      "key": "4d75b4f0a2a77b6624cb3147038e50cb",
      "relation": "hasVariant",
      "source": 80,
      "target": 88
    },
    {
      "key": "8ec125ceb1ce750c74b3e9db3099f339",
      "relation": "hasVariant",
      "source": 80,
      "target": 85
    },
    {
      "key": "0269f10a10de1492bd2c2e64dac5b919",
      "relation": "partOf",
      "source": 80,
      "target": 48
    },
    {
      "key": "22750997c4419a74204100b75d3aef36",
      "relation": "hasVariant",
      "source": 80,
      "target": 86
    },
    {
      "key": "9fc6f2f65b825f01138665892f45f724",
      "relation": "hasVariant",
      "source": 80,
      "target": 87
    },
    {
      "key": "186595ee82211cb6a20d9452dadb474f",
      "relation": "hasVariant",
      "source": 80,
      "target": 90
    },
    {
      "annotations": {
        "CellLine": {
          "B12 cell": true,
          "PC12": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Overexpression of HIF-1α has been shown to protect the rat sympathetic nerves-like cell line PC12, the central nervous system cell line B12, and primary cultured cortical neurons from Aβ-induced neurotoxicity [58], possibly through activating glycolytic and hexose monophosphate shunt-related enzymes.",
      "key": "47cdad890bd63294c814c2b1db9b5340",
      "line": 349,
      "relation": "increases",
      "source": 80,
      "target": 35
    },
    {
      "annotations": {
        "CellLine": {
          "B12 cell": true,
          "PC12": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Overexpression of HIF-1α has been shown to protect the rat sympathetic nerves-like cell line PC12, the central nervous system cell line B12, and primary cultured cortical neurons from Aβ-induced neurotoxicity [58], possibly through activating glycolytic and hexose monophosphate shunt-related enzymes.",
      "key": "3bed4a120db56b826be7f66b7fe9fa5f",
      "line": 350,
      "relation": "increases",
      "source": 80,
      "target": 39
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since GLUT-1 and GLUT-3 are target genes of HIF-1, induction of HIF-1α expression may restore the glucose uptake and postpone the progression of AD.",
      "key": "76d3a896af65e1fd2844c422ca555e8b",
      "line": 416,
      "relation": "increases",
      "source": 80,
      "target": 101
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since GLUT-1 and GLUT-3 are target genes of HIF-1, induction of HIF-1α expression may restore the glucose uptake and postpone the progression of AD.",
      "key": "d9a60768da6fd71e70e9209dae9d02f6",
      "line": 417,
      "relation": "increases",
      "source": 80,
      "target": 102
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since GLUT-1 and GLUT-3 are target genes of HIF-1, induction of HIF-1α expression may restore the glucose uptake and postpone the progression of AD.",
      "key": "0f8c73920a8fdfff7e4d51d3b9aabc3e",
      "line": 418,
      "relation": "decreases",
      "source": 80,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Meanwhile, a conditional knock-down of HIF-1α in mice results in a 40% decrease of TH expression in substantia nigra [86].",
      "key": "e99851475cb995a2e0a9110a561727eb",
      "line": 460,
      "relation": "increases",
      "source": 80,
      "target": 137
    },
    {
      "key": "d17058660ca5f793810b2657ee8aeb8b",
      "relation": "partOf",
      "source": 68,
      "target": 111
    },
    {
      "key": "84f40c4ae5e51e45d9490f2c5c39ecb4",
      "relation": "partOf",
      "source": 68,
      "target": 49
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The bHLH and PAS motifs are required for dimerization between HIF-1α and HIF-1β.",
      "key": "1dff41d936af1dae36ddea3cf01a1afe",
      "line": 86,
      "relation": "increases",
      "source": 108,
      "target": 111
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The bHLH and PAS motifs are required for dimerization between HIF-1α and HIF-1β.",
      "key": "e43f8c6e3ec7f56eaf703a3dadb9a4b9",
      "line": 87,
      "relation": "increases",
      "source": 115,
      "target": 111
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Under hypoxia, HIF-1α is stabilized and translocated to the nucleus where it dimerizes with HIF-1β [3].",
      "key": "a2835eeb5aeabd49c7b10c9607b1a8c1",
      "line": 91,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "nucleus",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 40,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "1b2f8a558ce5cc9f6e20ff23bbe0d75b",
      "line": 218,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 40,
      "target": 100
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF can induce angiogenesis and increase blood supply to motor neurons during hypoxia through action on endothelial cells [39].",
      "key": "84204950dca47c9807dfb2823d659b6d",
      "line": 248,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 40,
      "target": 106
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "043eefbb338f411ced8e0590e283c182",
      "line": 289,
      "relation": "increases",
      "source": 40,
      "target": 28
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Under hypoxia, HIF-1α is stabilized and translocated to the nucleus where it dimerizes with HIF-1β [3].",
      "key": "15115aa1bc488a6cf0a331414c4e24cd",
      "line": 93,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 49,
      "subject": {
        "location": {
          "name": "nucleus",
          "namespace": "GO"
        }
      },
      "target": 111
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The activated HIF-1 complex subsequently binds to hypoxic response elements (HREs) in the regulatory regions of genes and recruits co-transactivation factors such as CBP/p300 [CBP: CREB (cAMP-response element-binding protein)-binding protein/E1A-binding protein].",
      "key": "759091fc34693dc37813990f3d18cfbf",
      "line": 100,
      "relation": "increases",
      "source": 54,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The activated HIF-1 complex subsequently binds to hypoxic response elements (HREs) in the regulatory regions of genes and recruits co-transactivation factors such as CBP/p300 [CBP: CREB (cAMP-response element-binding protein)-binding protein/E1A-binding protein].",
      "key": "38e9fc0503353da1c5b92507521626d6",
      "line": 101,
      "relation": "increases",
      "source": 54,
      "target": 77
    },
    {
      "key": "c7d46a2f48ce313c6cc50411488be939",
      "relation": "partOf",
      "source": 113,
      "target": 54
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "ALS-like symptoms and neuropathology can be produced in mice by a targeted deletion of the hypoxia response element that eliminates the expression of VEGF in response to hypoxia [42].",
      "key": "f7908014ec184487dc2d66f9605ed610",
      "line": 262,
      "relation": "increases",
      "source": 113,
      "target": 106
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "ALS-like symptoms and neuropathology can be produced in mice by a targeted deletion of the hypoxia response element that eliminates the expression of VEGF in response to hypoxia [42].",
      "key": "2c580a6e7bb4d2b5f13d44cfc3df3dc0",
      "line": 263,
      "relation": "decreases",
      "source": 113,
      "target": 122
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "bc67d6ef5c85853bbed89a2cf83053b9",
      "line": 271,
      "relation": "negativeCorrelation",
      "source": 113,
      "subject": {
        "modifier": "Activity"
      },
      "target": 118
    },
    {
      "key": "180add1b5c8d474f03802ec71e313f71",
      "relation": "partOf",
      "source": 113,
      "target": 64
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Promoter activity studies suggest that the TH gene is under the control of a hypoxia response element [82–83].",
      "key": "ab38bdd6f4254bcd9ff039cb0c8b3524",
      "line": 445,
      "relation": "regulates",
      "source": 113,
      "target": 137
    },
    {
      "key": "d4d942122a381491acf676f522163e41",
      "relation": "partOf",
      "source": 72,
      "target": 50
    },
    {
      "key": "c45464c4fa4fbb8bc217047b1ab61a3e",
      "relation": "partOf",
      "source": 77,
      "target": 51
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "f690531f63a63365b2e29a7e19e25466",
      "line": 109,
      "relation": "increases",
      "source": 74,
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "bc60e7f7673464b79eaef037b951526c",
      "line": 110,
      "relation": "increases",
      "source": 74,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "1ecc485ecfd5c4db762eac73fe943694",
      "line": 124,
      "relation": "increases",
      "source": 83,
      "target": 52
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "a1567e45d0662caeddd2185a23e2f4a5",
      "line": 111,
      "relation": "increases",
      "source": 73,
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "41d614d0eea6357df4a94dfdccc56011",
      "line": 112,
      "relation": "increases",
      "source": 73,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "1df45665d038abad88fed4bb925a3d12",
      "line": 113,
      "relation": "increases",
      "source": 75,
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The hydroxylation is mediated by a family of prolyl hydroxylases, namely PHD1, PHD2, and PHD3 [12], among which PHD2 has the highest specificity for hydroxylation of HIF-1α [11].",
      "key": "faf647f4c9697c9f379be0ef3c896b3b",
      "line": 114,
      "relation": "increases",
      "source": 75,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "These PHD enzymes are 2-oxoglutarate-dependent dioxygenases and require oxygen as well as Fe2+ as cofactors [13–14].",
      "key": "d360d97be9b7338d1fbb8669c4f2e136",
      "line": 117,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 55,
      "target": 74
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "These PHD enzymes are 2-oxoglutarate-dependent dioxygenases and require oxygen as well as Fe2+ as cofactors [13–14].",
      "key": "1f28e52cc13f440a5619b3af6921257f",
      "line": 118,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 55,
      "target": 73
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "These PHD enzymes are 2-oxoglutarate-dependent dioxygenases and require oxygen as well as Fe2+ as cofactors [13–14].",
      "key": "456639f175c37b832d80f210b19944f1",
      "line": 119,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 55,
      "target": 75
    },
    {
      "key": "c329e4b004f823c70a7fcfa53c7a89b7",
      "relation": "partOf",
      "source": 1,
      "target": 55
    },
    {
      "key": "7f30d83445f69ceaf7c3e3af18e36f4c",
      "relation": "partOf",
      "source": 10,
      "target": 55
    },
    {
      "key": "68253ed71cfc70c6136bd015060201ac",
      "relation": "partOf",
      "source": 10,
      "target": 56
    },
    {
      "key": "98179097740f85449323b8930a472e92",
      "relation": "partOf",
      "source": 10,
      "target": 57
    },
    {
      "key": "805e4722e3aabf647fdcd39db424d8f4",
      "relation": "partOf",
      "source": 13,
      "target": 55
    },
    {
      "key": "c4f7cce68ee9f11c8b45dd08b7d3738a",
      "relation": "partOf",
      "source": 13,
      "target": 58
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "925d298ec462bb5ab031ba810b219f9f",
      "line": 126,
      "relation": "increases",
      "source": 52,
      "target": 91
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "ce164b55316ab5997eddeb7c148ac80c",
      "line": 153,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 52,
      "target": 80
    },
    {
      "key": "e43195aafb4762ff3f9c030602a09f81",
      "relation": "partOf",
      "source": 107,
      "target": 52
    },
    {
      "key": "2b606a294b45be8d5d7f2c601727f366",
      "relation": "partOf",
      "source": 91,
      "target": 63
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "b7ff21c25af619c0bcc44693dfdbc91e",
      "line": 127,
      "relation": "increases",
      "source": 91,
      "target": 63
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxylation promotes interaction of HIF-1α with the von Hippel-Lindau (pVHL) ubiquitin E3 ligase complex [15–16]. HIF-1α is thereby poly-ubiquitinated and degraded by the 26S proteasome [17–18].",
      "key": "be37156da0ab185151ebc95ae0494439",
      "line": 128,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 63,
      "target": 80
    },
    {
      "key": "27f472b9a4e271c6ad03ff4f45692ca3",
      "relation": "partOf",
      "source": 114,
      "target": 63
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "0203226fb0561d708a344442140595aa",
      "line": 133,
      "relation": "decreases",
      "source": 9,
      "target": 74
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "8349077e18a9f67acba78c898a8ca5b4",
      "line": 134,
      "relation": "decreases",
      "source": 9,
      "target": 73
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "a98be57715c1f27be44767f542c4691e",
      "line": 135,
      "relation": "decreases",
      "source": 9,
      "target": 75
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Since the PHDs employ non-heme iron in the catalytic moiety, it can be predicted that shortage of intracellular iron will result in inhibition of activity of PHDs and HIF-1 upregulation.",
      "key": "d4e8f53cc8606479818f248f3141e0b3",
      "line": 136,
      "relation": "increases",
      "source": 9,
      "target": 134
    },
    {
      "key": "ca4d655fb439cd36292b57f58bfb09e5",
      "relation": "partOf",
      "source": 9,
      "target": 56
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "8e1d9fd46eb7fef47571f9b96cb6c7a2",
      "line": 142,
      "relation": "increases",
      "source": 58,
      "target": 82
    },
    {
      "key": "c8008a6e02c772b72dcf91c13aee949c",
      "relation": "partOf",
      "source": 93,
      "target": 58
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "5a231a6ceb541e8470a6f9e487c53df0",
      "line": 143,
      "relation": "decreases",
      "source": 82,
      "target": 50
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "ae77687826155d234b4f79cd84a39de8",
      "line": 144,
      "relation": "decreases",
      "source": 82,
      "target": 51
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "c4783960e5500017f7e45d21ed5b47dd",
      "line": 145,
      "object": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 82,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "At the transcriptional level, oxygen availability enables hydroxylation of the asparagine residue 803 in the C-TAD of HIF-1α by factor inhibiting HIF (FIH-1), which blocks the association of HIF-1α with transcriptional co-activators CBP/ p300 and thus inhibits its transcriptional activity [20].",
      "key": "6658b337a22d110366174ba76aec54f5",
      "line": 146,
      "object": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 82,
      "target": 77
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "07912d35538b6439e4fc5f468fa99302",
      "line": 150,
      "relation": "increases",
      "source": 98,
      "target": 81
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "c7f99f3cd2b82370790d5f25bc54537c",
      "line": 152,
      "relation": "increases",
      "source": 98,
      "target": 52
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "3b9d5c9391ca193ef207b63274d5a8ed",
      "line": 154,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 98,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "K532 acetylation by the ARrest-Defective-1 (ARD-1) enhances the interaction between HIF-1α and pVHL and, thus, leads to increased ubiquitination and concomitant proteasomal degradation [21].",
      "key": "c1437623042d0b6a970382f6aa9716e8",
      "line": 151,
      "relation": "increases",
      "source": 81,
      "target": 52
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Mutation of lysine 532 to arginine has been reported to result in increased stability of overexpressed HIF-1α [22].",
      "key": "496fd5107ddc6d1c24abfc0a30a89315",
      "line": 157,
      "relation": "increases",
      "source": 92,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Direct phosphorylation on threonine 796 by mitogen-activated protein kinase (MAPK) has recently been identified as a novel modification on HIF-1α and is able to increase HIF-1 activity [23].",
      "key": "e0ca8a61822aa1715caf0de7f04fa0fe",
      "line": 162,
      "relation": "increases",
      "source": 109,
      "target": 89
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Direct phosphorylation on threonine 796 by mitogen-activated protein kinase (MAPK) has recently been identified as a novel modification on HIF-1α and is able to increase HIF-1 activity [23].",
      "key": "15a402fe5892d6e4257edb20eb0569dc",
      "line": 163,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 109,
      "target": 111
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "One mechanism to explain the increased transcriptional activity is that HIF-1β binds preferentially to the phosphorylated form of HIF-1α [24].",
      "key": "973e627d666013f567d1313a6f835926",
      "line": 166,
      "relation": "increases",
      "source": 89,
      "target": 49
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, it has been reported that phosphorylation at T796 in HIF-1α increases the affinity of the interaction between HIF-1α and the transcriptional co-activator CBP/p300 [25].",
      "key": "805ee3475132ef36865c0ce3f05e5848",
      "line": 171,
      "relation": "increases",
      "source": 89,
      "target": 50
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, it has been reported that phosphorylation at T796 in HIF-1α increases the affinity of the interaction between HIF-1α and the transcriptional co-activator CBP/p300 [25].",
      "key": "c26c756e6aadd0d38097ec8b567e3eda",
      "line": 172,
      "relation": "increases",
      "source": 89,
      "target": 51
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Consistent with this, it is found that phosphorylation of T796 prevents the hydroxylation of N803 by FIH [25].",
      "key": "a612de307f5fdfe00ff8c761abe3e1fc",
      "line": 176,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 89,
      "target": 93
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Consistent with this, it is found that phosphorylation of T796 prevents the hydroxylation of N803 by FIH [25].",
      "key": "c5258ec60eff1721ee3b321180165c53",
      "line": 177,
      "relation": "decreases",
      "source": 89,
      "target": 82
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Inhibition of these phosphorylation sites has been shown to impair both transcriptional activity and the nuclear localization of HIF-1α [26].",
      "key": "b0fe293889afd460b8ce2a9310820f2e",
      "line": 181,
      "object": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 89,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Inhibition of these phosphorylation sites has been shown to impair both transcriptional activity and the nuclear localization of HIF-1α [26].",
      "key": "8a6988619475eada161931f6d562a904",
      "line": 182,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "nucleus",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 89,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, phosphorylation of HIF-1α by glycogen synthase kinase (GSK)-3β may target HIF-1α for proteasomal degradation [26].",
      "key": "16a78950b2c41317469367656f27bbf7",
      "line": 186,
      "relation": "increases",
      "source": 79,
      "target": 88
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, phosphorylation of HIF-1α by glycogen synthase kinase (GSK)-3β may target HIF-1α for proteasomal degradation [26].",
      "key": "e2c31e79779d2e1f55fd7559323e47a0",
      "line": 187,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 88,
      "subject": {
        "effect": {
          "name": "proteasome binding",
          "namespace": "GO"
        },
        "modifier": "Activity"
      },
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxyl radical and hydrogen peroxide can destabilize HIF-1α protein in both normoxic and hypoxic conditions [27–28].",
      "key": "62ad9ca7344727ade466f7e201bebe39",
      "line": 191,
      "relation": "decreases",
      "source": 15,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hydroxyl radical and hydrogen peroxide can destabilize HIF-1α protein in both normoxic and hypoxic conditions [27–28].",
      "key": "ac245bccd10bbfe3e2865f366cb38277",
      "line": 192,
      "relation": "decreases",
      "source": 8,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The oxidized HIF-1α protein might be recognized and degraded by the ubiquitin-independent 20S proteasomal pathway, which primarily degrades cellular oxidized proteins under oxidative stress conditions [29].",
      "key": "461d436f7492d9e26836ea38d8694a67",
      "line": 198,
      "relation": "increases",
      "source": 85,
      "target": 48
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The oxidized HIF-1α protein might be recognized and degraded by the ubiquitin-independent 20S proteasomal pathway, which primarily degrades cellular oxidized proteins under oxidative stress conditions [29].",
      "key": "6c40f0dd013d9b5fa9b97da529d77b34",
      "line": 199,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 48,
      "target": 80
    },
    {
      "key": "a43758ec269a4d81cb9d72b689be5657",
      "relation": "partOf",
      "source": 20,
      "target": 48
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "02c6a9e076ed45b7f6b2603d263eb031",
      "line": 205,
      "relation": "increases",
      "source": 86,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "f9158bc525820221c101bcb0e327e0cf",
      "line": 206,
      "relation": "increases",
      "source": 87,
      "target": 50
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "03cbd58d3afe8ed4945a8c83ba34ae65",
      "line": 207,
      "relation": "increases",
      "source": 87,
      "target": 51
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, studies have revealed that S-nitrosation stabilizes HIF-1α protein and S-nitrosation of cysteine 800 of HIF-1α promotes its interaction with CBP/p300, thus enhancing HIF-1α activation [30].",
      "key": "11b90de77dc0123e26707e8c9ed79d24",
      "line": 208,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 87,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Sumoylation of HIF-1α has been reported to regulate its protein level and transcriptional activity.",
      "key": "53d65f7872361f0b6c8ba35adcc950a4",
      "line": 212,
      "relation": "regulates",
      "source": 90,
      "target": 134
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Sumoylation of HIF-1α has been reported to regulate its protein level and transcriptional activity.",
      "key": "5fc26d0b1396b08f5fa14c00329fc255",
      "line": 213,
      "object": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 90,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "fed533e1927b0842c73e831c34691bdf",
      "line": 221,
      "relation": "increases",
      "source": 90,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "b9adff6f67b963910485d86ee1449deb",
      "line": 219,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 100,
      "subject": {
        "modifier": "Activity"
      },
      "target": 105
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Increasing the activity of RWD-containing sumoylation enhancer (RSUME) could promote the sumoylation of HIF-1α by Ubc9 SUMO conjugase and stabilize HIF-1α during hypoxia [32].",
      "key": "97f196c006771e1ecda1372c569f519b",
      "line": 220,
      "relation": "increases",
      "source": 105,
      "target": 90
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "However, desumoylation by SUMO-Specific Protease 1 (SENP-1) has been shown to be essential for the stabilization of HIF-1α [33].",
      "key": "c22545b8a4123b0fa46088117ef3e5f0",
      "line": 226,
      "relation": "decreases",
      "source": 110,
      "target": 90
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "However, desumoylation by SUMO-Specific Protease 1 (SENP-1) has been shown to be essential for the stabilization of HIF-1α [33].",
      "key": "4435b5ca2bdc3f57b0ba31a381b9ef97",
      "line": 227,
      "relation": "regulates",
      "source": 110,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "32e3ec19f7ef47e3fc54d4847f7bcd4b",
      "line": 236,
      "relation": "negativeCorrelation",
      "source": 120,
      "target": 32
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "9dd8752053844a92dcc7e8a6e5512df4",
      "line": 239,
      "relation": "increases",
      "source": 120,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "0c942c73d12da67281dbf98c79c66369",
      "line": 236,
      "relation": "negativeCorrelation",
      "source": 32,
      "target": 120
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "aeee13cdb244cf838b4ee70495c15c95",
      "line": 237,
      "relation": "negativeCorrelation",
      "source": 32,
      "target": 125
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "096b683eb28847099646c8a17f362cfa",
      "line": 238,
      "relation": "decreases",
      "source": 32,
      "target": 38
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "acdeeb8c4b11b3bfe45586a5e4260dbf",
      "line": 237,
      "relation": "negativeCorrelation",
      "source": 125,
      "target": 32
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "a4243dc4d9bc3f805640baa70546c64a",
      "line": 240,
      "relation": "increases",
      "source": 125,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that individuals who have suffered severe hypoxia or ischemia are more susceptible to developing AD [63].",
      "key": "5a6266a57c1ed002e565f5a3fc198e2a",
      "line": 377,
      "relation": "increases",
      "source": 125,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "9fb377ffdb3ba8d6e8f3cd51db18f9c1",
      "line": 388,
      "relation": "increases",
      "source": 125,
      "target": 70
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "a05c395baed6a9dfc5b87a3a5a3cf852",
      "line": 389,
      "relation": "increases",
      "source": 125,
      "target": 47
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "0e9f8bf1aa8ca920dbc61a0a475ef01b",
      "line": 392,
      "relation": "increases",
      "source": 125,
      "target": 6
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "770b19776020f8fc0ffb43b90a555491",
      "line": 393,
      "relation": "increases",
      "source": 125,
      "target": 17
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hypoxia and DFO, both are known to upregulate HIF-1, can increase TH expression in rat brains [84–85].",
      "key": "760e7792ac9b6fa22412520b54130a93",
      "line": 451,
      "relation": "increases",
      "source": 125,
      "target": 137
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This lack of glucose and oxygen fails to meet the energy requirement of motor neurons, which will in turn induce neuronal death and lead to the occurrence of ALS.",
      "key": "4975c1489ef75ca9983860f1e08bd18e",
      "line": 241,
      "relation": "increases",
      "source": 38,
      "target": 118
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "3599be817b09f52a7ca65e27c856a81c",
      "line": 256,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 118,
      "target": 106
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "20fb12e829d6393b72cd37716b940be0",
      "line": 271,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 118,
      "target": 113
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that EPO levels are significantly decreased in cerebrospinal fluids from patients with differing severity and duration of ALS [46], while EPO immunoreacitivity is significantly increased in midbrain, brain stem, and cortex of the SOD1G93A mutant mice [47].",
      "key": "2f987e12f65d5897158cce4f5b97160f",
      "line": 300,
      "relation": "decreases",
      "source": 118,
      "target": 78
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF can induce angiogenesis and increase blood supply to motor neurons during hypoxia through action on endothelial cells [39].",
      "key": "c496f6cd828fbd32b8e4d1f5e1fb582b",
      "line": 249,
      "relation": "increases",
      "source": 106,
      "target": 27
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "By this mechanism, VEGF can prevent the death of motor neurons and postpone the occurrence of ALS.",
      "key": "9fb279ca6b0f3cce7a5c20d3d63d3459",
      "line": 280,
      "relation": "increases",
      "source": 106,
      "target": 27
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "86bf1e826db7f128981222974df67fa8",
      "line": 255,
      "relation": "negativeCorrelation",
      "source": 106,
      "target": 124
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "301e14d99d908b3c61ddd99f5ddf56ec",
      "line": 256,
      "relation": "negativeCorrelation",
      "source": 106,
      "subject": {
        "modifier": "Activity"
      },
      "target": 118
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true,
          "Spinal Cord": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "By this mechanism, VEGF can prevent the death of motor neurons and postpone the occurrence of ALS.",
      "key": "c8833a296f49c39e6e3bcf3ab375038d",
      "line": 281,
      "relation": "decreases",
      "source": 106,
      "target": 118
    },
    {
      "key": "537473d948e6f98c9b563d2c450c8ce4",
      "relation": "partOf",
      "source": 106,
      "target": 53
    },
    {
      "annotations": {
        "Cell": {
          "dopaminergic neuron": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In an embryonic rat explant model, DAergic neurons, particularly, exhibit increased survival in response to VEGF application [92], suggesting that VEGF may promote the growth of DAergic neurons.",
      "key": "51928a0a1f4108e4e3f52afcdc55ada7",
      "line": 531,
      "relation": "increases",
      "source": 106,
      "target": 19
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, a mouse model of pan-neuronal overexpression of VEGF demonstrates that VEGF provides protection against MPTP toxicity in nigral cells [88].",
      "key": "c98ef02193147f89f6217dcc1ab68305",
      "line": 538,
      "relation": "decreases",
      "source": 106,
      "target": 28
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "There is a negative correlation between the VEGF level and the severity of hypoxemia in patients with ALS, which suggests a deregulation of VEGF in ALS [40–41].",
      "key": "cd2bd6eeb5de1d6ab0788c5e9b3ad7b9",
      "line": 255,
      "relation": "negativeCorrelation",
      "source": 124,
      "target": 106
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "881a176d74d054a93fd8ca1e8e4e6b17",
      "line": 272,
      "relation": "decreases",
      "source": 64,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "This indicates that an impaired HIF-1-VEGF pathway may contribute to the pathogenesis of ALS. Furthermore, overexpression of VEGF in SOD1G93A mutant mice delays the degeneration of motor neurons and neuronal death and prolongs the survival of these ALS mice [43].",
      "key": "da4c3d9bd5b8aed26c489c2030262c67",
      "line": 273,
      "relation": "decreases",
      "source": 64,
      "target": 129
    },
    {
      "key": "47807a4dabf733f508ee5c3d12f9cb52",
      "relation": "partOf",
      "source": 104,
      "target": 64
    },
    {
      "annotations": {
        "Anatomy": {
          "brainstem": true,
          "cortex": true,
          "midbrain": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that EPO levels are significantly decreased in cerebrospinal fluids from patients with differing severity and duration of ALS [46], while EPO immunoreacitivity is significantly increased in midbrain, brain stem, and cortex of the SOD1G93A mutant mice [47].",
      "key": "8fc3c797c00c27fb776aea13051a3471",
      "line": 304,
      "relation": "increases",
      "source": 104,
      "target": 78
    },
    {
      "key": "fb50aa351fa3da48a87d15c07b9ac097",
      "relation": "partOf",
      "source": 104,
      "target": 62
    },
    {
      "key": "665207989464c6cc55a6487f9862362a",
      "relation": "partOf",
      "source": 104,
      "target": 61
    },
    {
      "key": "e1d27e6f900a66a1e674ad25592095d0",
      "relation": "hasVariant",
      "source": 103,
      "target": 104
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "74314a1ee89ca2c01eaf73ec44a90464",
      "line": 290,
      "relation": "decreases",
      "source": 53,
      "target": 28
    },
    {
      "key": "5fa609c4f84f8dd81769b5f66dc170de",
      "relation": "partOf",
      "source": 99,
      "target": 53
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "bf65c7cd6582ed5446e8f5b41b51a489",
      "line": 291,
      "relation": "association",
      "source": 99,
      "target": 26
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Motor Neurons": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "VEGF supports the survival of primary motor neurons and a motor-like cell line in vitro and could protect these motor neurons from hypoxia-induced cell death by binding with neuropilin-1, a receptor known to be involved in axon guidance during development [42, 45].",
      "key": "6e3a3c9de11bdfa5ce319eac59e2533a",
      "line": 291,
      "relation": "association",
      "source": 26,
      "target": 99
    },
    {
      "key": "7fa8bacfbc779a6c08e5ca90c4f3e6a8",
      "relation": "partOf",
      "source": 78,
      "target": 62
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that EPO is able to block the Aβ-generated neuronal apoptosis and that this protection is completely abolished by co-treatment with an anti-EPO neutralizing antibody [70].",
      "key": "71301a2b02e64bfbff891df099ba3bf7",
      "line": 424,
      "relation": "decreases",
      "source": 78,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that EPO is able to block the Aβ-generated neuronal apoptosis and that this protection is completely abolished by co-treatment with an anti-EPO neutralizing antibody [70].",
      "key": "f9c793bc544e5a20797563e8f69ebbb9",
      "line": 425,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 78,
      "target": 17
    },
    {
      "annotations": {
        "CellLine": {
          "MN9D": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "EPO is neuroprotective against the DAergic neurotoxin, 6- hydroxydopamine, in both the DAergic cell line MN9D and primary DAergic neurons [91].",
      "key": "0e3d291adbacd7cf5a31991e009d8bdb",
      "line": 523,
      "relation": "decreases",
      "source": 78,
      "target": 16
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this SOD1G93A mutant mouse ALS model, administration of EPO suppresses the onset and progression of ALS by preventing motor neuron death and inflammation [48–49].",
      "key": "8fbccaa8da7ff4cf56e9df233153bc68",
      "line": 311,
      "relation": "decreases",
      "source": 62,
      "target": 118
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this SOD1G93A mutant mouse ALS model, administration of EPO suppresses the onset and progression of ALS by preventing motor neuron death and inflammation [48–49].",
      "key": "fbb61185141cd792bb648504c04143a5",
      "line": 312,
      "relation": "decreases",
      "source": 62,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this SOD1G93A mutant mouse ALS model, administration of EPO suppresses the onset and progression of ALS by preventing motor neuron death and inflammation [48–49].",
      "key": "ec3be6863ae4cbc7b642d19d7965e4d4",
      "line": 313,
      "relation": "decreases",
      "source": 62,
      "target": 36
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "1488c559fd9f05051ffcc9d3d18743d7",
      "line": 320,
      "relation": "positiveCorrelation",
      "source": 25,
      "target": 111
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "1a8cdc9df47841117294497610734516",
      "line": 321,
      "relation": "decreases",
      "source": 25,
      "target": 37
    },
    {
      "key": "52b2a36b626bebd4e6c92f0407e83a80",
      "relation": "partOf",
      "source": 25,
      "target": 61
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The HIF-1 inducer, M30, has been reported to increase the HIF-1α protein level and elevate expression of the HIF-1 target genes, VEGF and EPO.",
      "key": "7d0d6d7c4bffb4992409cbf2a3d39879",
      "line": 332,
      "relation": "increases",
      "source": 25,
      "target": 134
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The HIF-1 inducer, M30, has been reported to increase the HIF-1α protein level and elevate expression of the HIF-1 target genes, VEGF and EPO.",
      "key": "e07d3e77c97bd0a6ae892db6d8ab1f66",
      "line": 333,
      "relation": "increases",
      "source": 25,
      "target": 133
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The HIF-1 inducer, M30, has been reported to increase the HIF-1α protein level and elevate expression of the HIF-1 target genes, VEGF and EPO.",
      "key": "64d11ee06d91cc99a2361ed2fb994343",
      "line": 334,
      "relation": "increases",
      "source": 25,
      "target": 138
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that M30 simultaneously attenuates tau phosphorylation and protects cortical neurons against Aβ (25– 35) toxicity [57].",
      "key": "dc018d55fcf906eab1aa09c445e1f541",
      "line": 339,
      "relation": "decreases",
      "source": 25,
      "target": 97
    },
    {
      "annotations": {
        "Anatomy": {
          "cortex": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been reported that M30 simultaneously attenuates tau phosphorylation and protects cortical neurons against Aβ (25– 35) toxicity [57].",
      "key": "b2834fd1117d12ca1007f23c6249b3c7",
      "line": 341,
      "relation": "decreases",
      "source": 25,
      "target": 127
    },
    {
      "key": "335d51bc28c8a473ecadc56aaf1d5896",
      "relation": "partOf",
      "source": 25,
      "target": 60
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "21a98d8feebe10442b10bfe5b4f961b8",
      "line": 641,
      "relation": "increases",
      "source": 25,
      "target": 76
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "1063b71dd3bbff334ec50a04164b79e6",
      "line": 643,
      "relation": "increases",
      "source": 25,
      "target": 106
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "1b67530d124be785963073463b204e1a",
      "line": 645,
      "relation": "increases",
      "source": 25,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Indeed, the iron chelator M30, which up-regulates HIF-1 expression, protects NSC-34 motor neuron cells from oxidative damage in vitro and significantly delays the onset of ALS in SOD1G93A mutant mice [50] (Table 2).",
      "key": "8873fb3bc67532d9d38c80ea6fbdb310",
      "line": 323,
      "relation": "decreases",
      "source": 61,
      "target": 118
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 96,
      "target": 97
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Deferoxamine (DFO), a widely used HIF-1 inducer, has been used in clinical trial in AD patients and slowed cognitive decline [59].",
      "key": "5589192e4b1f2810c856555f208f6a5e",
      "line": 356,
      "relation": "increases",
      "source": 22,
      "target": 111
    },
    {
      "annotations": {
        "CellLine": {
          "C6 cell": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Preconditioning of C6 astroglial cells with DFO can activate HIF-1 and thereby attenuate cytotoxicity induced by mitochondrial inhibitor 3-nitropropionic acid [102].",
      "key": "c467e8849fea89d6160196686844bbb1",
      "line": 617,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 22,
      "target": 111
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Deferoxamine (DFO), a widely used HIF-1 inducer, has been used in clinical trial in AD patients and slowed cognitive decline [59].",
      "key": "8339b3ee5986ddcf0a80d221b98f516c",
      "line": 357,
      "relation": "decreases",
      "source": 22,
      "target": 42
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Deferoxamine (DFO), a widely used HIF-1 inducer, has been used in clinical trial in AD patients and slowed cognitive decline [59].",
      "key": "c87759941e179913d4e8472134e06ada",
      "line": 358,
      "relation": "decreases",
      "source": 22,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Hypoxia and DFO, both are known to upregulate HIF-1, can increase TH expression in rat brains [84–85].",
      "key": "eff0fa4cd1a66b259bdbbc7bce83310d",
      "line": 452,
      "relation": "increases",
      "source": 22,
      "target": 137
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, DFO is shown to prevent neurotoxicity in the MPTP-mouse model of PD [89].",
      "key": "8ed5845e7922183e00f408ce2e12520a",
      "line": 507,
      "relation": "decreases",
      "source": 22,
      "target": 130
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Ventricles": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, Ben-Shachar et al. have demonstrated that intracerebroventricular-injection of DFO protects the rat brain from DAergic neurodegeneration induced by 6-hydroxydopamine [90].",
      "key": "b6e27039e86509ffff8d106d75d6bc6e",
      "line": 516,
      "relation": "decreases",
      "source": 22,
      "target": 119
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Glioma": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "956e26894d737a968090cb5774f5f71f",
      "line": 571,
      "relation": "negativeCorrelation",
      "source": 22,
      "target": 132
    },
    {
      "annotations": {
        "CellLine": {
          "C6 cell": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Preconditioning of C6 astroglial cells with DFO can activate HIF-1 and thereby attenuate cytotoxicity induced by mitochondrial inhibitor 3-nitropropionic acid [102].",
      "key": "f16f5711817c0271fa3b638142a4ea2e",
      "line": 618,
      "relation": "decreases",
      "source": 22,
      "target": 132
    },
    {
      "key": "af5dd96c7a33cfcaf8e1d1f6b11fe38c",
      "relation": "partOf",
      "source": 22,
      "target": 57
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "e9cf2f67057bdb8b3e7eeeb55572d04f",
      "line": 370,
      "relation": "decreases",
      "source": 116,
      "target": 46
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "5f363a7b06b7861ad659997c6800ee1e",
      "line": 371,
      "relation": "negativeCorrelation",
      "source": 116,
      "target": 34
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "59006ce7c3dbb1249828ea981ebee4f9",
      "line": 372,
      "relation": "negativeCorrelation",
      "source": 116,
      "target": 33
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "d14061c9b409e85c3e020063aaf25d80",
      "line": 373,
      "relation": "increases",
      "source": 116,
      "target": 45
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "4cdae782e97373b9835dd8952644b5ae",
      "line": 408,
      "relation": "decreases",
      "source": 116,
      "target": 135
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "2b6b4b2eb090b59d3909091cd033289a",
      "line": 409,
      "relation": "decreases",
      "source": 116,
      "target": 136
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "90a96f81e87c9f45f5d604cd4881b398",
      "line": 371,
      "relation": "negativeCorrelation",
      "source": 34,
      "target": 116
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is known that reduced cerebral blood flow [60], impaired glucose uptake and metabolism [61], and increased oxidative stress [62] are involved in the pathogenesis of AD.",
      "key": "d71fa1663a220b0a27d7a007dbc79f87",
      "line": 372,
      "relation": "negativeCorrelation",
      "source": 33,
      "target": 116
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that individuals who have suffered severe hypoxia or ischemia are more susceptible to developing AD [63].",
      "key": "e39eb1454d83e481634cbb68c5f48414",
      "line": 378,
      "relation": "increases",
      "source": 121,
      "target": 116
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "77c2fe5a9ea719555af65cf793e627a7",
      "line": 390,
      "relation": "increases",
      "source": 47,
      "target": 6
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In brains of transgenicAD mice, hypoxia elevates the β-cleavage of amyloid-β precursor protein and increases the expression of γ-secretase, which in turn increases Aβ generation and senile plaque formation [66].",
      "key": "0c44db3b1c6df2fd194616b5cb56cf02",
      "line": 391,
      "relation": "increases",
      "source": 47,
      "target": 17
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been shown that EPO is able to block the Aβ-generated neuronal apoptosis and that this protection is completely abolished by co-treatment with an anti-EPO neutralizing antibody [70].",
      "key": "0430e014154c6bd277b78332ef83e7fb",
      "line": 423,
      "relation": "increases",
      "source": 17,
      "target": 38
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "d38b952e809053c5966be761b1529b5d",
      "line": 410,
      "relation": "regulates",
      "source": 101,
      "target": 33
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The reduced glucose uptake is due to decreased expressions of neuronal glucose transporters (GLUT-1 and GLUT-3) [67].",
      "key": "aea6be0583844c63ebbb33153cc98f3e",
      "line": 411,
      "relation": "regulates",
      "source": 102,
      "target": 33
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10090": true,
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is reported that MPTP treatment inhibits HIF-1α accumulation in dopaminergic cell lines PC12 and in mice [80], suggesting that HIF-1 activity is impaired in PD.",
      "key": "f4f092218e6d85af5852c515be63b8fb",
      "line": 437,
      "relation": "decreases",
      "source": 0,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The research group also reported that the iron chelator clioquinol increases HIF-1α within DAergic neurons and protects against MPTP-induced nigral cell death [88].",
      "key": "54bf9a49af356e79c0eff940bb58979b",
      "line": 499,
      "relation": "increases",
      "source": 0,
      "target": 28
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, DFO is shown to prevent neurotoxicity in the MPTP-mouse model of PD [89].",
      "key": "24f5a4c1ea33c9e60aad378d5c3ed35c",
      "line": 506,
      "relation": "increases",
      "source": 0,
      "target": 130
    },
    {
      "annotations": {
        "CellLine": {
          "PC12": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10090": true,
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It is reported that MPTP treatment inhibits HIF-1α accumulation in dopaminergic cell lines PC12 and in mice [80], suggesting that HIF-1 activity is impaired in PD.",
      "key": "c78184c2d2a4bb4073727adaa09bd897",
      "line": 438,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 117,
      "target": 111
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Injection of the PHD inhibitor FG0041 increases HIF-1 activity and the extracellular DA level in the striatum of the rat brain [87].",
      "key": "19ff72e1c47d5750f429fc3cc89d0109",
      "line": 468,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 21,
      "target": 111
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Injection of the PHD inhibitor FG0041 increases HIF-1 activity and the extracellular DA level in the striatum of the rat brain [87].",
      "key": "e6e6e73c04c33c348bce55f560fde1ab",
      "line": 469,
      "object": {
        "location": {
          "name": "extracellular region",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 21,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, administration of HIF-1 activator cobalt chloride raises the DA release [87].",
      "key": "c368875354bb48f950a66a9a87509ce5",
      "line": 475,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 7,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, administration of HIF-1 activator cobalt chloride raises the DA release [87].",
      "key": "61193c4de0f0e9c3f32b62cf46bbe748",
      "line": 476,
      "relation": "increases",
      "source": 7,
      "target": 111
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Glioma": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "3dca3119cfb47ea390dbad934c790eb4",
      "line": 569,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 132
    },
    {
      "annotations": {
        "CellLine": {
          "C6 cell": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Moreover, the preconditioning of rat C6 astroglia cells with the CoCl2 provides extensive cytoprotective effects against metabolic insults induced by mitochondrial toxin 3-nitropropionic acid [102].",
      "key": "b5c1f8a25712de8cc8f57385dd7f10c7",
      "line": 600,
      "relation": "increases",
      "source": 7,
      "target": 131
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been found that 3,4-DHB treatment is able to stabilize HIF-1α protein, leading to the elevation of HIF-1 target genes expression, such as ferroportin and heme oxygenase (HO)-1, in the substantia nigra.",
      "key": "e99e761c53cfef8164bedb422880c776",
      "line": 489,
      "relation": "increases",
      "source": 2,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been found that 3,4-DHB treatment is able to stabilize HIF-1α protein, leading to the elevation of HIF-1 target genes expression, such as ferroportin and heme oxygenase (HO)-1, in the substantia nigra.",
      "key": "f195af5ae03433b2c6759f5b8293b83d",
      "line": 490,
      "relation": "increases",
      "source": 2,
      "target": 66
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "It has been found that 3,4-DHB treatment is able to stabilize HIF-1α protein, leading to the elevation of HIF-1 target genes expression, such as ferroportin and heme oxygenase (HO)-1, in the substantia nigra.",
      "key": "f711624172398b74a4d6178bf65356a8",
      "line": 491,
      "relation": "increases",
      "source": 2,
      "target": 65
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, 3,4-DHB also elevates the expression of HIF-dependent genes such as heme oxygenase-1 and manganese superoxide dismutase in the presence of MPTP [88].",
      "key": "87bd1884eb6e39040576725507f6ca55",
      "line": 654,
      "relation": "increases",
      "source": 2,
      "target": 67
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The research group also reported that the iron chelator clioquinol increases HIF-1α within DAergic neurons and protects against MPTP-induced nigral cell death [88].",
      "key": "59a55a3ddf5924ec5a1d9e4047dd8d5e",
      "line": 497,
      "relation": "increases",
      "source": 4,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Substantia Nigra": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The research group also reported that the iron chelator clioquinol increases HIF-1α within DAergic neurons and protects against MPTP-induced nigral cell death [88].",
      "key": "3604c44b4b88ba752013624c3afb927c",
      "line": 500,
      "relation": "decreases",
      "source": 4,
      "target": 28
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Another metal chelator, clioquinol, increases HIF-1α expression and reduces cell death and mutant protein accumulation in both a tissue culture model and a transgenic Huntington’s animal model [101–102].",
      "key": "7c629bbce43ffa505f79c0c99ad3a7a5",
      "line": 578,
      "relation": "decreases",
      "source": 4,
      "target": 18
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Clioquinol-treated transgenic HD mice (R6/2) demonstrate improved behavioral and pathologic phenotypes, including decreased huntingtin aggregate accumulation as well as enhanced motor functions and survival [101].",
      "key": "b24c6e126d2d1068ed5eaa7203cd2fee",
      "line": 626,
      "relation": "decreases",
      "source": 4,
      "target": 126
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Clioquinol-treated transgenic HD mice (R6/2) demonstrate improved behavioral and pathologic phenotypes, including decreased huntingtin aggregate accumulation as well as enhanced motor functions and survival [101].",
      "key": "4a22ef17cb118664bd0ae3b03c1d2ddc",
      "line": 627,
      "relation": "increases",
      "source": 4,
      "target": 123
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Ventricles": true
        },
        "MeSHDisease": {
          "Parkinson Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In addition, Ben-Shachar et al. have demonstrated that intracerebroventricular-injection of DFO protects the rat brain from DAergic neurodegeneration induced by 6-hydroxydopamine [90].",
      "key": "c7339d9831481d3e8626372ec74a9283",
      "line": 515,
      "relation": "increases",
      "source": 16,
      "target": 119
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this way, huntingtin protein-induced mitochondrial metabolism dysfunction in the brain serves as the primary cause of HD pathogenesis.",
      "key": "3c83563a7cdae2546a35cc1e19fc54c8",
      "line": 548,
      "relation": "negativeCorrelation",
      "source": 95,
      "target": 128
    },
    {
      "key": "0ce6657d55cebf519ec5f8609a572687",
      "relation": "hasVariant",
      "source": 94,
      "target": 95
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "In this way, huntingtin protein-induced mitochondrial metabolism dysfunction in the brain serves as the primary cause of HD pathogenesis.",
      "key": "375d0e4f702da8e1299f7c7d86a32658",
      "line": 548,
      "relation": "negativeCorrelation",
      "source": 128,
      "target": 95
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Glioma": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "3e1ad9ea592b72d9975e657b5064a227",
      "line": 569,
      "relation": "negativeCorrelation",
      "source": 132,
      "target": 7
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Glioma": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "afc9db6ac9f3f5d2c283f24601552561",
      "line": 570,
      "relation": "negativeCorrelation",
      "source": 132,
      "target": 5
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Glioma": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "9f17b622170c3aa7a91eb94d1d442951",
      "line": 571,
      "relation": "negativeCorrelation",
      "source": 132,
      "target": 22
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Glioma": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "4e42eaf11f56eb50d39e4af549b19a7b",
      "line": 570,
      "relation": "negativeCorrelation",
      "source": 5,
      "target": 132
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Glioma": true
        }
      },
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Three HIF-1 inducers, CoCl2, mimosine, and DFO, have been reported to significantly attenuate cytotoxicity induced by 3-nitropropionic acid in glioma cells.",
      "key": "a70d425835907f2813d05b37f8723102",
      "line": 572,
      "relation": "increases",
      "source": 3,
      "target": 132
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "6cd635cc625d2f5604b138faca335089",
      "line": 590,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 112,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "351a5c08482134cad8145307a1247dd5",
      "line": 592,
      "relation": "increases",
      "source": 112,
      "target": 119
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "8f32fa37b0640883a7231d90070bd686",
      "line": 591,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 69,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "PHDs can induce HIF-1α degradation while FIH inhibits HIF-1 activity. Inhibiting the hydroxylases has been shown to provide protective effects in neurodegenerative diseases",
      "key": "25958f5264204bd1b5ed21433eb697c9",
      "line": 593,
      "relation": "increases",
      "source": 69,
      "target": 119
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Iron chelators have been traditionally regarded to provide neuroprotection by sequestering redox-active iron and thereby prevent hydroxyl radical formation [106].",
      "key": "1226ede09febeb61eab933c99d76708d",
      "line": 606,
      "relation": "decreases",
      "source": 56,
      "target": 15
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "The sequestering of ferrous ion by DFO prevents formation of a catalytically active center in the PHDs and induces HIF-1 activation [11].",
      "key": "8133936881653a8afa97d28a8b69a4f9",
      "line": 611,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 57,
      "target": 111
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "M30 and another iron chelator HLA20 (Fig. 1.4) are both designed from the brain-permeable iron chelator VK28 (Fig. 1.5) and chemically attached to the neuroprotective N-propargyl moiety of the anti-Parkinson drug rasageline.",
      "key": "78294c06d2e0a7a5b9e1272f5db929c7",
      "line": 634,
      "relation": "decreases",
      "source": 60,
      "target": 117
    },
    {
      "key": "27e3dbafaf9f9b07ece31edfe5720a15",
      "relation": "partOf",
      "source": 23,
      "target": 60
    },
    {
      "key": "584312a2e9c2d54a5e3f8c2f55ca05c8",
      "relation": "partOf",
      "source": 23,
      "target": 59
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "M30 and another iron chelator HLA20 (Fig. 1.4) are both designed from the brain-permeable iron chelator VK28 (Fig. 1.5) and chemically attached to the neuroprotective N-propargyl moiety of the anti-Parkinson drug rasageline.",
      "key": "732472288317eefacaaf820f47db2a69",
      "line": 635,
      "relation": "decreases",
      "source": 59,
      "target": 117
    },
    {
      "key": "9a94b6286bf953f1947d084ad804fcfd",
      "relation": "partOf",
      "source": 24,
      "target": 59
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "596e67b37047052601ddc8d9589c4c0f",
      "line": 642,
      "relation": "increases",
      "source": 24,
      "target": 76
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "29da62f3ebed15fd2035d2c9f876a3fc",
      "line": 644,
      "relation": "increases",
      "source": 24,
      "target": 106
    },
    {
      "citation": {
        "authors": [
          "Chang Y",
          "Shi H",
          "ShiDu Yan S",
          "Yan J",
          "Zhang Z"
        ],
        "date": "2011-01-01",
        "db": "PubMed",
        "db_id": "21861815",
        "db_name": "Hypoxia inducible factor-1 as a target for neurodegenerative diseases.",
        "first": "Zhang Z",
        "journal": "Current medicinal chemistry",
        "last": "Shi H",
        "pages": "4335-43",
        "volume": "18"
      },
      "evidence": "Furthermore, both M30 and HLA20 increase the levels of the endogenous HIF-1-dependent genes, including enolase-1, VEGF, and brain derived neurotrophic factor (BDNF) in NSC-34 cells [50].",
      "key": "e8d345e3d91b31e6ca707499f27866d7",
      "line": 646,
      "relation": "increases",
      "source": 24,
      "target": 71
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\")",
      "concept": {
        "name": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "429d8cf3b81b74b8cc50a6d837424a61"
    },
    {
      "bel": "a(CHEBI:\"2-oxoglutarate(1-)\")",
      "concept": {
        "name": "2-oxoglutarate(1-)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "de54d713839cc6a58835a52125bf81db"
    },
    {
      "bel": "a(CHEBI:\"3,4-dihydroxybenzoate\")",
      "concept": {
        "name": "3,4-dihydroxybenzoate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ec230da79dfc68723e0b7fcfa09946d3"
    },
    {
      "bel": "a(CHEBI:\"3-nitropropanoic acid\")",
      "concept": {
        "name": "3-nitropropanoic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "eb92df215e7b704aeb702301bcef9d67"
    },
    {
      "bel": "a(CHEBI:\"5-chloro-7-iodoquinolin-8-ol\")",
      "concept": {
        "name": "5-chloro-7-iodoquinolin-8-ol",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "26a4b86350a0f79a56a7dbf84e05d132"
    },
    {
      "bel": "a(CHEBI:\"L-mimosine\")",
      "concept": {
        "name": "L-mimosine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e7f2d429c1403c2cf3c1acf8a22a3a89"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"cobalt dichloride\")",
      "concept": {
        "name": "cobalt dichloride",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a8851a41593d338d63bf1fbf24f84c53"
    },
    {
      "bel": "a(CHEBI:\"hydrogen peroxide\")",
      "concept": {
        "name": "hydrogen peroxide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "2a33dd72d09a3b66f80326bcf6e3bfd6"
    },
    {
      "bel": "a(CHEBI:\"iron chelator\")",
      "concept": {
        "name": "iron chelator",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "6b62ab97bce3a64c53b321a3fcb3c2f8"
    },
    {
      "bel": "a(CHEBI:\"iron(2+)\")",
      "concept": {
        "name": "iron(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "be7ed197cc239803fafad58c7dc415ba"
    },
    {
      "bel": "a(CHEBI:ATP)",
      "concept": {
        "name": "ATP",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "08c2bd47cf55782389bbaba34887a39c"
    },
    {
      "bel": "a(CHEBI:NADPH)",
      "concept": {
        "name": "NADPH",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "20e6cc8f83eabc7a776ebf34466f49da"
    },
    {
      "bel": "a(CHEBI:dioxygen)",
      "concept": {
        "name": "dioxygen",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "bbe161dd595b582241898258462de427"
    },
    {
      "bel": "a(CHEBI:dopamine)",
      "concept": {
        "name": "dopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4c950dc480c64069e58998401b2083c1"
    },
    {
      "bel": "a(CHEBI:hydroxyl)",
      "concept": {
        "name": "hydroxyl",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "085e62ac8ad7bca76ee6367f02410631"
    },
    {
      "bel": "a(CHEBI:oxidopamine)",
      "concept": {
        "name": "oxidopamine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8a3aa6c226d61ff2f130381a1636366f"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "concept": {
        "name": "amyloid-beta aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "cb9ddfdb593aa8073305b79828d71376"
    },
    {
      "bel": "a(CONSO:\"huntingtin aggregates\")",
      "concept": {
        "name": "huntingtin aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "ddfb3dfcec37bcf8a1201a85c5723c38"
    },
    {
      "bel": "a(MESH:\"Dopaminergic Neurons\")",
      "concept": {
        "name": "Dopaminergic Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "47bd22a33070cbf256cd62473e57ed0b"
    },
    {
      "bel": "a(NCIT:C13737)",
      "concept": {
        "name": "C13737",
        "namespace": "NCIT"
      },
      "function": "Abundance",
      "id": "703c8c347fa9a77846755cbb29c29275"
    },
    {
      "bel": "a(PUBCHEM:137275695)",
      "concept": {
        "name": "137275695",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "4fbd878fe0190fdb3c6f5d5aacc86d1f"
    },
    {
      "bel": "a(PUBCHEM:2973)",
      "concept": {
        "name": "2973",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "667de31ab8c2cd640c339162ce163b06"
    },
    {
      "bel": "a(PUBCHEM:3052776)",
      "concept": {
        "name": "3052776",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "76618d48d72b37702e81e5699fca608a"
    },
    {
      "bel": "a(PUBCHEM:6918819)",
      "concept": {
        "name": "6918819",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "2620d8c98924d93e522701a298bd05b8"
    },
    {
      "bel": "a(PUBCHEM:6918822)",
      "concept": {
        "name": "6918822",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "9ba59056bd19c74213cb3567956dd85b"
    },
    {
      "bel": "bp(GO:\"axon guidance\")",
      "concept": {
        "name": "axon guidance",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5e1e928fbee57451c4342b253ca64a03"
    },
    {
      "bel": "bp(GO:\"blood vessel development\")",
      "concept": {
        "name": "blood vessel development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c687ec7b1e72a3254276f98626f2c786"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "concept": {
        "name": "cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "07a2f2734c3682bcb47105485c15b346"
    },
    {
      "bel": "bp(GO:\"cell redox homeostasis\")",
      "concept": {
        "name": "cell redox homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f8e747e89cd7da5dcbc9c2cadff662c4"
    },
    {
      "bel": "bp(GO:\"cellular response to oxidative stress\")",
      "concept": {
        "name": "cellular response to oxidative stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "97bc042e019a8c4bc942ab08644c5f86"
    },
    {
      "bel": "bp(GO:\"cellular response to oxygen-glucose deprivation\")",
      "concept": {
        "name": "cellular response to oxygen-glucose deprivation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "2ac11bb46c68dee2589a9f3c01622500"
    },
    {
      "bel": "bp(GO:\"energy homeostasis\")",
      "concept": {
        "name": "energy homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d350b37fb24c6e9ace1f29d8faf883ea"
    },
    {
      "bel": "bp(GO:\"glucose import\")",
      "concept": {
        "name": "glucose import",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f57bac670efe08d9a46dfe9b4e490b74"
    },
    {
      "bel": "bp(GO:\"glucose metabolic process\")",
      "concept": {
        "name": "glucose metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "57837c8bd480cd6e4257602591b12dac"
    },
    {
      "bel": "bp(GO:\"glycolytic process\")",
      "concept": {
        "name": "glycolytic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "de85d9d53df85cf1d871ae538e4286b3"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"neuron death in response to oxidative stress\")",
      "concept": {
        "name": "neuron death in response to oxidative stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a56452128add0e25ccff634b67eb42ce"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"pentose-phosphate shunt\")",
      "concept": {
        "name": "pentose-phosphate shunt",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "44f00ff8fb0b1922f4c83c65afbb1a13"
    },
    {
      "bel": "bp(GO:\"response to hypoxia\")",
      "concept": {
        "name": "response to hypoxia",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8c5505b03e1e564975e18380c4d05f0c"
    },
    {
      "bel": "bp(GO:angiogenesis)",
      "concept": {
        "name": "angiogenesis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3d6fd378871feec80135a583c419e7f1"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(NCIT:C16407)",
      "concept": {
        "name": "C16407",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "a354f6f9fd43df07a23e5ea709988efb"
    },
    {
      "bel": "bp(NCIT:C16559)",
      "concept": {
        "name": "C16559",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "28aaf8757d534e110927a237d5602ccb"
    },
    {
      "bel": "bp(NCIT:C17741)",
      "concept": {
        "name": "C17741",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "bd9579b6c4a167581395e09818647e73"
    },
    {
      "bel": "bp(NCIT:C94869)",
      "concept": {
        "name": "C94869",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "8f756a3ae4fb744e5d3d89cb2988c49b"
    },
    {
      "bel": "complex(GO:\"gamma-secretase complex\")",
      "concept": {
        "name": "gamma-secretase complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "cb9f772c242dc7192de1b4f6180ecaa5"
    },
    {
      "bel": "complex(a(NCIT:C13737), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "ad563e6d7c5232b981ec6845d644df62",
      "members": [
        {
          "bel": "a(NCIT:C13737)",
          "concept": {
            "name": "C13737",
            "namespace": "NCIT"
          },
          "function": "Abundance",
          "id": "703c8c347fa9a77846755cbb29c29275"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:ARNT), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "05e2f768d03ef28a3dc82c50e4dab4e5",
      "members": [
        {
          "bel": "p(HGNC:ARNT)",
          "concept": {
            "name": "ARNT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "56ea0628bda070becb2f1f805e31ff2f"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CREBBP), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "30d5e97143b7d691f58542011d96b85d",
      "members": [
        {
          "bel": "p(HGNC:CREBBP)",
          "concept": {
            "name": "CREBBP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "46148e81658994544d74b5db695e5cd8"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:EP300), p(HGNC:HIF1A))",
      "function": "Complex",
      "id": "55865d469c6bf1e40ce3175a63dba729",
      "members": [
        {
          "bel": "p(HGNC:EP300)",
          "concept": {
            "name": "EP300",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "e20d8e85f8a2efec4b3796446b8aa684"
        },
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HIF1A), p(HGNC:VHL))",
      "function": "Complex",
      "id": "d631d4374e98b4ff97ee5decc61c8a5f",
      "members": [
        {
          "bel": "p(HGNC:HIF1A)",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
        },
        {
          "bel": "p(HGNC:VHL)",
          "concept": {
            "name": "VHL",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "51ee7ec3981d10efa166f95b9b4fc8d0"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:NRP1), p(HGNC:VEGFA))",
      "function": "Complex",
      "id": "745be4a09f6cb7c6e38af59c00f894be",
      "members": [
        {
          "bel": "p(HGNC:NRP1)",
          "concept": {
            "name": "NRP1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "281ebbfe33238809d916d5f4b5d90d98"
        },
        {
          "bel": "p(HGNC:VEGFA)",
          "concept": {
            "name": "VEGFA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "3537912f85b0c685b323cfa4aaff98c1"
        }
      ]
    },
    {
      "bel": "complex(p(MESH:\"Hypoxia-Inducible Factor 1\"), p(NCIT:C13718))",
      "function": "Complex",
      "id": "8b39a302493673aa4d5ba9b637bd92a4",
      "members": [
        {
          "bel": "p(MESH:\"Hypoxia-Inducible Factor 1\")",
          "concept": {
            "name": "Hypoxia-Inducible Factor 1",
            "namespace": "MESH"
          },
          "function": "Protein",
          "id": "4e348c44a211012bbb3e2f65fe3081ba"
        },
        {
          "bel": "p(NCIT:C13718)",
          "concept": {
            "name": "C13718",
            "namespace": "NCIT"
          },
          "function": "Protein",
          "id": "543bd74118561c4ee9d67403c9b8256a"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"2-oxoglutarate(1-)\"), a(CHEBI:\"iron(2+)\"), a(CHEBI:dioxygen))",
      "function": "Composite",
      "id": "8ce01a14c56e9328bc20932bb16a54d1",
      "members": [
        {
          "bel": "a(CHEBI:\"2-oxoglutarate(1-)\")",
          "concept": {
            "name": "2-oxoglutarate(1-)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "de54d713839cc6a58835a52125bf81db"
        },
        {
          "bel": "a(CHEBI:\"iron(2+)\")",
          "concept": {
            "name": "iron(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "be7ed197cc239803fafad58c7dc415ba"
        },
        {
          "bel": "a(CHEBI:dioxygen)",
          "concept": {
            "name": "dioxygen",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "bbe161dd595b582241898258462de427"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"iron chelator\"), a(CHEBI:\"iron(2+)\"))",
      "function": "Composite",
      "id": "620337bf20b9ce982bb603e71c5b6e7a",
      "members": [
        {
          "bel": "a(CHEBI:\"iron chelator\")",
          "concept": {
            "name": "iron chelator",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "6b62ab97bce3a64c53b321a3fcb3c2f8"
        },
        {
          "bel": "a(CHEBI:\"iron(2+)\")",
          "concept": {
            "name": "iron(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "be7ed197cc239803fafad58c7dc415ba"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"iron(2+)\"), a(PUBCHEM:2973))",
      "function": "Composite",
      "id": "36d4ad5d691aef51c622a40d04666ed7",
      "members": [
        {
          "bel": "a(CHEBI:\"iron(2+)\")",
          "concept": {
            "name": "iron(2+)",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "be7ed197cc239803fafad58c7dc415ba"
        },
        {
          "bel": "a(PUBCHEM:2973)",
          "concept": {
            "name": "2973",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "667de31ab8c2cd640c339162ce163b06"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:dioxygen), p(HGNC:HIF1AN))",
      "function": "Composite",
      "id": "147e53292ce5c10558c6194fc8f9508b",
      "members": [
        {
          "bel": "a(CHEBI:dioxygen)",
          "concept": {
            "name": "dioxygen",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "bbe161dd595b582241898258462de427"
        },
        {
          "bel": "p(HGNC:HIF1AN)",
          "concept": {
            "name": "HIF1AN",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "6d8d1becde78925aa097d4902e95ac7a"
        }
      ]
    },
    {
      "bel": "composite(a(PUBCHEM:3052776), a(PUBCHEM:6918819))",
      "function": "Composite",
      "id": "4efa208a72bb83812f2523118e3e22d6",
      "members": [
        {
          "bel": "a(PUBCHEM:3052776)",
          "concept": {
            "name": "3052776",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "76618d48d72b37702e81e5699fca608a"
        },
        {
          "bel": "a(PUBCHEM:6918819)",
          "concept": {
            "name": "6918819",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "2620d8c98924d93e522701a298bd05b8"
        }
      ]
    },
    {
      "bel": "composite(a(PUBCHEM:3052776), a(PUBCHEM:6918822))",
      "function": "Composite",
      "id": "709d01fd0504168f9524454121aab68b",
      "members": [
        {
          "bel": "a(PUBCHEM:3052776)",
          "concept": {
            "name": "3052776",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "76618d48d72b37702e81e5699fca608a"
        },
        {
          "bel": "a(PUBCHEM:6918822)",
          "concept": {
            "name": "6918822",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "9ba59056bd19c74213cb3567956dd85b"
        }
      ]
    },
    {
      "bel": "composite(a(PUBCHEM:6918822), p(HGNC:SOD1, var(\"Gly93Ala\")))",
      "function": "Composite",
      "id": "f89604a8504c0450465c7ff8bec25214",
      "members": [
        {
          "bel": "a(PUBCHEM:6918822)",
          "concept": {
            "name": "6918822",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "9ba59056bd19c74213cb3567956dd85b"
        },
        {
          "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
          "concept": {
            "name": "SOD1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "615aac3bc7de5afe7a6d65c647adfd16",
          "variants": [
            {
              "hgvs": "Gly93Ala",
              "kind": "hgvs"
            }
          ]
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:EPO), p(HGNC:SOD1, var(\"Gly93Ala\")))",
      "function": "Composite",
      "id": "f965f0fd0ddd767ecab3212698b64f84",
      "members": [
        {
          "bel": "p(HGNC:EPO)",
          "concept": {
            "name": "EPO",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "25000a2f97feb5507a44691b0fd5a366"
        },
        {
          "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
          "concept": {
            "name": "SOD1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "615aac3bc7de5afe7a6d65c647adfd16",
          "variants": [
            {
              "hgvs": "Gly93Ala",
              "kind": "hgvs"
            }
          ]
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:HIF1A, pmod(Ub)), p(NCIT:C13970))",
      "function": "Composite",
      "id": "e5fa2656dfc2d6f6ca8bdecd91f163e2",
      "members": [
        {
          "bel": "p(HGNC:HIF1A, pmod(Ub))",
          "concept": {
            "name": "HIF1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "558f148047233cc1f23c065dc9cec25d",
          "variants": [
            {
              "concept": {
                "name": "Ub",
                "namespace": "bel"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(NCIT:C13970)",
          "concept": {
            "name": "C13970",
            "namespace": "NCIT"
          },
          "function": "Protein",
          "id": "5d2ad7617b22c9e31ec98493d0d94588"
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:SOD1, var(\"Gly93Ala\")), p(NCIT:C13718))",
      "function": "Composite",
      "id": "9c9d72102df8df1cd0fe89606996c89f",
      "members": [
        {
          "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
          "concept": {
            "name": "SOD1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "615aac3bc7de5afe7a6d65c647adfd16",
          "variants": [
            {
              "hgvs": "Gly93Ala",
              "kind": "hgvs"
            }
          ]
        },
        {
          "bel": "p(NCIT:C13718)",
          "concept": {
            "name": "C13718",
            "namespace": "NCIT"
          },
          "function": "Protein",
          "id": "543bd74118561c4ee9d67403c9b8256a"
        }
      ]
    },
    {
      "bel": "g(HGNC:HMOX1)",
      "concept": {
        "name": "HMOX1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "d8c8fde724f6e9b21d709b9bd79ec563"
    },
    {
      "bel": "g(HGNC:SLC40A1)",
      "concept": {
        "name": "SLC40A1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "c4490067606c982ff6657037aff39796"
    },
    {
      "bel": "g(HGNC:SOD1)",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "30c6a726629f949afcafd8cebbd3ff37"
    },
    {
      "bel": "p(HGNC:ARNT)",
      "concept": {
        "name": "ARNT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "56ea0628bda070becb2f1f805e31ff2f"
    },
    {
      "bel": "p(HGNC:ASPH)",
      "concept": {
        "name": "ASPH",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e0873dbcbd4589d81f34ad4c709d1b9b"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "334dd03e9a5f223f13995e497b1c156e"
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:CREBBP)",
      "concept": {
        "name": "CREBBP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "46148e81658994544d74b5db695e5cd8"
    },
    {
      "bel": "p(HGNC:EGLN1)",
      "concept": {
        "name": "EGLN1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c4717bf543c3a7038331f50cbc3bc673"
    },
    {
      "bel": "p(HGNC:EGLN2)",
      "concept": {
        "name": "EGLN2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "53659ecdbb07cf0542e2fb5579dea84d"
    },
    {
      "bel": "p(HGNC:EGLN3)",
      "concept": {
        "name": "EGLN3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b626b92928b114201a4cafad356c75e3"
    },
    {
      "bel": "p(HGNC:ENO1)",
      "concept": {
        "name": "ENO1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a6b29776b451be82b0b36b69cd1dd5a7"
    },
    {
      "bel": "p(HGNC:EP300)",
      "concept": {
        "name": "EP300",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e20d8e85f8a2efec4b3796446b8aa684"
    },
    {
      "bel": "p(HGNC:EPO)",
      "concept": {
        "name": "EPO",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "25000a2f97feb5507a44691b0fd5a366"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "concept": {
        "name": "GSK3B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8eaf29c9e491ff4e49619e77de92467c"
    },
    {
      "bel": "p(HGNC:HIF1A)",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "589a3a55500d0b280fdfeb11b3a4c4b3"
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Ac, Lys, 532))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2850a9bd340f38ec458327595c002be9",
      "variants": [
        {
          "code": "Lys",
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 532
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Hy, Asn, 803))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3de3fb3e605d53a0203206a3fd6f0484",
      "variants": [
        {
          "code": "Asn",
          "concept": {
            "name": "Hy",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 803
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Hy, Pro, 402))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "84adedd812db9f0c0d6d9adf6a91829b",
      "variants": [
        {
          "code": "Pro",
          "concept": {
            "name": "Hy",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 402
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Hy, Pro, 546))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0c0782b925769507fb1d71008c1665cf",
      "variants": [
        {
          "code": "Pro",
          "concept": {
            "name": "Hy",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 546
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(NCIT:C16944))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bbcb41baaec72f06b62008642ac399d2",
      "variants": [
        {
          "concept": {
            "name": "C16944",
            "namespace": "NCIT"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(NO))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e6d6e60069b261ee9d22c26869fa8a12",
      "variants": [
        {
          "concept": {
            "name": "NO",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(NO, Cys, 800))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "94b68385f2566c36acb4b204015b3b44",
      "variants": [
        {
          "code": "Cys",
          "concept": {
            "name": "NO",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 800
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Ph))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "28009cad580d896bbcb13cb6f3407cda",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Ph, Thr, 796))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5fd0f340662a17e97b3462452e145b38",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 796
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Sumo))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "769c7d815980068fbd94f2c13f509e71",
      "variants": [
        {
          "concept": {
            "name": "Sumo",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, pmod(Ub))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "558f148047233cc1f23c065dc9cec25d",
      "variants": [
        {
          "concept": {
            "name": "Ub",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1A, var(\"p.Lys532?\"))",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ae8d0387f619678738238f696dc035d6",
      "variants": [
        {
          "hgvs": "p.Lys532?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:HIF1AN)",
      "concept": {
        "name": "HIF1AN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "6d8d1becde78925aa097d4902e95ac7a"
    },
    {
      "bel": "p(HGNC:HTT)",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b06bc161685303d07e7b94f740920bb7"
    },
    {
      "bel": "p(HGNC:HTT, pmod(CONSO:\"CAG repeats\"))",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5878ef11015a6336bfafc7255b6f926f",
      "variants": [
        {
          "concept": {
            "name": "CAG repeats",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:NAA10)",
      "concept": {
        "name": "NAA10",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f14384f25177674b6b2ca5d15576ea2b"
    },
    {
      "bel": "p(HGNC:NRP1)",
      "concept": {
        "name": "NRP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "281ebbfe33238809d916d5f4b5d90d98"
    },
    {
      "bel": "p(HGNC:RWDD3)",
      "concept": {
        "name": "RWDD3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "959ef5a9b3bb6808bb34800857ef0e8f"
    },
    {
      "bel": "p(HGNC:SLC2A1)",
      "concept": {
        "name": "SLC2A1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0685a7a8e864ce5e9ee91d28f007ba7b"
    },
    {
      "bel": "p(HGNC:SLC2A3)",
      "concept": {
        "name": "SLC2A3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dfc7bd3fb30ad4a8c7a13847cdb01ba8"
    },
    {
      "bel": "p(HGNC:SOD1)",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "706116ed914ade77428db2dcc85fff62"
    },
    {
      "bel": "p(HGNC:SOD1, var(\"Gly93Ala\"))",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "615aac3bc7de5afe7a6d65c647adfd16",
      "variants": [
        {
          "hgvs": "Gly93Ala",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:UBE2I)",
      "concept": {
        "name": "UBE2I",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "04324d5a1da0ddb8c8aa75e7244d82e3"
    },
    {
      "bel": "p(HGNC:VEGFA)",
      "concept": {
        "name": "VEGFA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3537912f85b0c685b323cfa4aaff98c1"
    },
    {
      "bel": "p(HGNC:VHL)",
      "concept": {
        "name": "VHL",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "51ee7ec3981d10efa166f95b9b4fc8d0"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Basic helix-loop-helix proteins\")",
      "concept": {
        "name": "Basic helix-loop-helix proteins",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "a948586e7556949b96089c5b831f8b61"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Mitogen-activated protein kinases\")",
      "concept": {
        "name": "Mitogen-activated protein kinases",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "1d67605932fe18429a72c45866d1bb26"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"SUMO specific peptidases\")",
      "concept": {
        "name": "SUMO specific peptidases",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "8b2b00d40eb190d7af500e9cbbffede9"
    },
    {
      "bel": "p(MESH:\"Hypoxia-Inducible Factor 1\")",
      "concept": {
        "name": "Hypoxia-Inducible Factor 1",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "4e348c44a211012bbb3e2f65fe3081ba"
    },
    {
      "bel": "p(MESH:\"Prolyl Hydroxylases\")",
      "concept": {
        "name": "Prolyl Hydroxylases",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "cca3954fb9af116baf07bf1554db6d59"
    },
    {
      "bel": "p(NCIT:C13718)",
      "concept": {
        "name": "C13718",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "543bd74118561c4ee9d67403c9b8256a"
    },
    {
      "bel": "p(NCIT:C13970)",
      "concept": {
        "name": "C13970",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "5d2ad7617b22c9e31ec98493d0d94588"
    },
    {
      "bel": "p(PFAM:PAS)",
      "concept": {
        "name": "PAS",
        "namespace": "PFAM"
      },
      "function": "Protein",
      "id": "7dbe282b6d7fc84f66da534e82961b2f"
    },
    {
      "bel": "path(DOID:\"Alzheimer's disease\")",
      "concept": {
        "name": "Alzheimer's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bab8638a4ae2b144ee036438e0a858da"
    },
    {
      "bel": "path(DOID:\"Parkinson's disease\")",
      "concept": {
        "name": "Parkinson's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "76019b99765efff85f16f73b8c6f082e"
    },
    {
      "bel": "path(DOID:\"amyotrophic lateral sclerosis\")",
      "concept": {
        "name": "amyotrophic lateral sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "c85c0e42ab7cd0643e9447a4444d00ef"
    },
    {
      "bel": "path(DOID:\"neurodegenerative disease\")",
      "concept": {
        "name": "neurodegenerative disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "9005fde45d3d20011ddb308da0266009"
    },
    {
      "bel": "path(DOID:hypoglycemia)",
      "concept": {
        "name": "hypoglycemia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "369cede7855a63b26505fa5301b08af5"
    },
    {
      "bel": "path(DOID:ischemia)",
      "concept": {
        "name": "ischemia",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "0635fd8d7348483eff5fbaca8b8879d1"
    },
    {
      "bel": "path(DOID:neuropathy)",
      "concept": {
        "name": "neuropathy",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "943823133ae72d328485574207be5347"
    },
    {
      "bel": "path(EFO:\"physical activity\")",
      "concept": {
        "name": "physical activity",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "baa4509c260af69bb969f841aec8c855"
    },
    {
      "bel": "path(EFO:hypoxemia)",
      "concept": {
        "name": "hypoxemia",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "3ea85c5d80fe523ee05dec11e374fa41"
    },
    {
      "bel": "path(EFO:hypoxia)",
      "concept": {
        "name": "hypoxia",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "7b851fa11c82749104da1713c9bda8ef"
    },
    {
      "bel": "path(HP:\"Behavioral abnormality\")",
      "concept": {
        "name": "Behavioral abnormality",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "c8fef1e5030ad7c31e28a857df357d02"
    },
    {
      "bel": "path(MESH:\"Amyloid Neuropathies\")",
      "concept": {
        "name": "Amyloid Neuropathies",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c7ab8ffebf0a9a5635be4e5c59d58864"
    },
    {
      "bel": "path(MESH:\"Mitochondrial Dynamics\")",
      "concept": {
        "name": "Mitochondrial Dynamics",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e78c74d1b1e902783c97f007cd19f3dc"
    },
    {
      "bel": "path(MESH:\"Motor Disorders\")",
      "concept": {
        "name": "Motor Disorders",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2e3b041e894813b580bde665989837d0"
    },
    {
      "bel": "path(MESH:\"Neurotoxicity Syndromes\")",
      "concept": {
        "name": "Neurotoxicity Syndromes",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "74054e2d9d497286c20c13bc68742e6c"
    },
    {
      "bel": "path(MESH:Cytoprotection)",
      "concept": {
        "name": "Cytoprotection",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "776b38e1b35d02d1137c0f03b18c1290"
    },
    {
      "bel": "path(NCIT:C27988)",
      "concept": {
        "name": "C27988",
        "namespace": "NCIT"
      },
      "function": "Pathology",
      "id": "9e6f34209a5189dbbe963802ff98ff2c"
    },
    {
      "bel": "r(HGNC:EPO)",
      "concept": {
        "name": "EPO",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "04cbe9e55170d027518f95e5eea1030d"
    },
    {
      "bel": "r(HGNC:HIF1A)",
      "concept": {
        "name": "HIF1A",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "3013a3a1b70f5df06d604d47ce4eb76b"
    },
    {
      "bel": "r(HGNC:SLC2A1)",
      "concept": {
        "name": "SLC2A1",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "9a6498745116802d48fd010bc697c04e"
    },
    {
      "bel": "r(HGNC:SLC2A3)",
      "concept": {
        "name": "SLC2A3",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "7345aed57b9854e72e012b28fcb14703"
    },
    {
      "bel": "r(HGNC:TH)",
      "concept": {
        "name": "TH",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "c33c26c9805bbb35ccdf493e65829253"
    },
    {
      "bel": "r(HGNC:VEGFA)",
      "concept": {
        "name": "VEGFA",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "cc401b6f151e43641f18bb07734b2722"
    }
  ]
}